- Report
- October 2024
- 185 Pages
Global
From €3228EUR$3,545USD£2,801GBP
€3587EUR$3,939USD£3,112GBP
- Report
- December 2024
- 100 Pages
Global
From €5418EUR$5,950USD£4,701GBP
- Report
- March 2025
- 175 Pages
Global
From €4089EUR$4,490USD£3,547GBP
- Report
- August 2024
- 161 Pages
Global
From €2277EUR$2,500USD£1,975GBP
- Report
- January 2025
- 154 Pages
Global
From €2641EUR$2,900USD£2,291GBP
- Report
- October 2024
- 182 Pages
Global
From €3228EUR$3,545USD£2,801GBP
€3587EUR$3,939USD£3,112GBP
- Report
- December 2024
- 110 Pages
Global
From €5418EUR$5,950USD£4,701GBP
- Report
- February 2025
- 148 Pages
Global
From €4417EUR$4,850USD£3,832GBP
- Report
- November 2024
- 750 Pages
Global
From €1685EUR$1,850USD£1,462GBP
- Report
- November 2024
- 750 Pages
Global
From €1685EUR$1,850USD£1,462GBP
- Report
- February 2025
- 40 Pages
United States
From €1097EUR$1,205USD£952GBP
- Report
- February 2025
- 218 Pages
Global
From €4370EUR$4,799USD£3,791GBP
- Report
- October 2024
- 199 Pages
Global
From €3228EUR$3,545USD£2,801GBP
€3587EUR$3,939USD£3,112GBP
- Report
- October 2024
- 184 Pages
Global
From €3228EUR$3,545USD£2,801GBP
€3587EUR$3,939USD£3,112GBP
- Report
- October 2024
- 186 Pages
Global
From €3228EUR$3,545USD£2,801GBP
€3587EUR$3,939USD£3,112GBP
- Report
- October 2024
- 196 Pages
Global
From €3228EUR$3,545USD£2,801GBP
€3587EUR$3,939USD£3,112GBP
- Report
- March 2025
- 189 Pages
Global
From €3228EUR$3,545USD£2,801GBP
€3587EUR$3,939USD£3,112GBP
- Report
- October 2024
- 199 Pages
Global
From €3228EUR$3,545USD£2,801GBP
€3587EUR$3,939USD£3,112GBP
- Report
- October 2024
- 197 Pages
Global
From €3228EUR$3,545USD£2,801GBP
€3587EUR$3,939USD£3,112GBP
- Report
- October 2024
- 186 Pages
Global
From €3228EUR$3,545USD£2,801GBP
€3587EUR$3,939USD£3,112GBP

The insulin market is a subset of the larger endocrine and metabolic disorders drugs market. Insulin is a hormone produced by the pancreas that helps regulate the body's blood sugar levels. It is used to treat diabetes, a condition in which the body does not produce enough insulin or is unable to use it effectively. Insulin is available in both short-acting and long-acting forms, and is typically administered via injection or an insulin pump.
The insulin market is highly competitive, with a number of major pharmaceutical companies offering a variety of insulin products. These include Eli Lilly, Novo Nordisk, Sanofi, and Merck. Additionally, there are a number of smaller companies that specialize in the production of insulin, such as Biocon, Wockhardt, and Wockhardt USA. Show Less Read more